Please login to the form below

Not currently logged in
Email:
Password:

Alexion Pharmaceuticals adds to its board

Judith Reinsdorf recently worked at Johnson Controls

Alexion Pharmaceuticals has appointed Judith Reinsdorf to its board of directors following her role as executive vice president and general counsel of Johnson Controls.

Reinsdorf, who has a background in corporate governance and expertise in managing corporate and legal affairs, has served in various positions for companies including Tyco International and Monsanto.

David Brennan, chairman of the board, said: “We are pleased to welcome Judy to Alexion’s board of directors.

“She brings strong corporate governance and legal expertise, with a proven track records in global compliance, strategic planning, data privacy and regulatory matters.

“Her broad experience at large US public companies, both within and outside the healthcare industry, will be a valuable addition to our board.”

Reinsdorf joins at a time when the company aims to “strengthen its leadership position in rare diseases”.

She said: “I am excited to join Alexion’s board of directors at a pivotal time for the company as it executes its strategy to deliver sustainable growth and I look forward to applying my experience to help guide Alexion’s future success.”

In addition, director Ann Veneman has also announced that she does not plan to stand for re-election as she will be retiring following eight years of service.

5th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

Tapping the potential of rare diseases: A journey into uncharted territory
...
The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...

Infographics